The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Medicine Market Research Report 2024
Synopsis
Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man 's best friend took a be the most iconic. But it' s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required.
The global Pet Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 33%.
This report aims to provide a comprehensive presentation of the global market for Pet Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medicine.
Report Scope
The Pet Medicine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Dechra Pharmaceuticals
Segment by Type
External Use
Internal Use
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man 's best friend took a be the most iconic. But it' s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required.
The global Pet Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 33%.
This report aims to provide a comprehensive presentation of the global market for Pet Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medicine.
Report Scope
The Pet Medicine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Dechra Pharmaceuticals
Segment by Type
External Use
Internal Use
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pet Medicine Market Overview
1.1 Product Overview and Scope of Pet Medicine
1.2 Pet Medicine Segment by Type
1.2.1 Global Pet Medicine Market Value Comparison by Type (2024-2030)
1.2.2 External Use
1.2.3 Internal Use
1.3 Pet Medicine Segment by Application
1.3.1 Global Pet Medicine Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pet Medicine Market Size Estimates and Forecasts
1.4.1 Global Pet Medicine Revenue 2019-2030
1.4.2 Global Pet Medicine Sales 2019-2030
1.4.3 Global Pet Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Medicine Market Competition by Manufacturers
2.1 Global Pet Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Pet Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medicine, Product Type & Application
2.7 Pet Medicine Market Competitive Situation and Trends
2.7.1 Pet Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Medicine Players Market Share by Revenue
2.7.3 Global Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Medicine Retrospective Market Scenario by Region
3.1 Global Pet Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Medicine Global Pet Medicine Sales by Region: 2019-2030
3.2.1 Global Pet Medicine Sales by Region: 2019-2024
3.2.2 Global Pet Medicine Sales by Region: 2025-2030
3.3 Global Pet Medicine Global Pet Medicine Revenue by Region: 2019-2030
3.3.1 Global Pet Medicine Revenue by Region: 2019-2024
3.3.2 Global Pet Medicine Revenue by Region: 2025-2030
3.4 North America Pet Medicine Market Facts & Figures by Country
3.4.1 North America Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Medicine Sales by Country (2019-2030)
3.4.3 North America Pet Medicine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Medicine Market Facts & Figures by Country
3.5.1 Europe Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Medicine Sales by Country (2019-2030)
3.5.3 Europe Pet Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Medicine Market Facts & Figures by Country
3.7.1 Latin America Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Medicine Sales by Country (2019-2030)
3.7.3 Latin America Pet Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Medicine Sales by Type (2019-2030)
4.1.1 Global Pet Medicine Sales by Type (2019-2024)
4.1.2 Global Pet Medicine Sales by Type (2025-2030)
4.1.3 Global Pet Medicine Sales Market Share by Type (2019-2030)
4.2 Global Pet Medicine Revenue by Type (2019-2030)
4.2.1 Global Pet Medicine Revenue by Type (2019-2024)
4.2.2 Global Pet Medicine Revenue by Type (2025-2030)
4.2.3 Global Pet Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Pet Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Medicine Sales by Application (2019-2030)
5.1.1 Global Pet Medicine Sales by Application (2019-2024)
5.1.2 Global Pet Medicine Sales by Application (2025-2030)
5.1.3 Global Pet Medicine Sales Market Share by Application (2019-2030)
5.2 Global Pet Medicine Revenue by Application (2019-2030)
5.2.1 Global Pet Medicine Revenue by Application (2019-2024)
5.2.2 Global Pet Medicine Revenue by Application (2025-2030)
5.2.3 Global Pet Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Pet Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Pet Medicine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Pet Medicine Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Pet Medicine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Pet Medicine Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Pet Medicine Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Pet Medicine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.6.1 Ceva Sante Animale Corporation Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sante Animale Pet Medicine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Pet Medicine Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Bimeda Animal Health
6.9.1 Bimeda Animal Health Corporation Information
6.9.2 Bimeda Animal Health Description and Business Overview
6.9.3 Bimeda Animal Health Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bimeda Animal Health Pet Medicine Product Portfolio
6.9.5 Bimeda Animal Health Recent Developments/Updates
6.10 Dechra Pharmaceuticals
6.10.1 Dechra Pharmaceuticals Corporation Information
6.10.2 Dechra Pharmaceuticals Description and Business Overview
6.10.3 Dechra Pharmaceuticals Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dechra Pharmaceuticals Pet Medicine Product Portfolio
6.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medicine Industry Chain Analysis
7.2 Pet Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medicine Production Mode & Process
7.4 Pet Medicine Sales and Marketing
7.4.1 Pet Medicine Sales Channels
7.4.2 Pet Medicine Distributors
7.5 Pet Medicine Customers
8 Pet Medicine Market Dynamics
8.1 Pet Medicine Industry Trends
8.2 Pet Medicine Market Drivers
8.3 Pet Medicine Market Challenges
8.4 Pet Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
